Page last updated: 2024-12-06
tridiphane
Cross-References
ID Source | ID |
PubMed CID | 73669 |
CHEBI ID | 82251 |
SCHEMBL ID | 54378 |
MeSH ID | M0146454 |
Synonyms (25)
Synonym |
tridiphane |
(.+/-.)-2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane |
oxirane, 2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)- |
epa pesticide chemical code 123901 |
nelpon |
tridiphane [ansi:bsi:iso] |
dowco 356 |
(rs)-2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane |
2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane |
58138-08-2 |
C19130 |
z5677lqe6j , |
unii-z5677lqe6j |
SCHEMBL54378 |
tridiphane [iso] |
tridiphane [mi] |
CHEBI:82251 |
IBZHOAONZVJLOB-UHFFFAOYSA-N |
2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane # |
DTXSID8024365 |
oxirane, 2-(3,5-dichlorophenyl)-2-(2,2,2-trichloroethyl)-; dowco 356; nelpon; tridiphane |
tridiphane 10 microg/ml in isooctane |
Q22809031 |
EN300-11790710 |
Z2050021249 |
Research Excerpts
Toxicity
Pharmacokinetics
Dosage Studied
Drug Classes (1)
Class | Description |
dichlorobenzene | Any member of the class of chlorobenzenes carrying two chloro groups at unspecified positions. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.89
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 21.89 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.39 (4.65) | Search Engine Demand Index | 18.60 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |